Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000950117-12-000223)

Filing Details

Accession Number:: 0000950117-12-000223
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-02-01 17:04:24
Reporting Period:: 2012-01-30

Filing Date:: 2012-02-01
Accepted Time:: 2012-02-01 17:04:24
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1420720	Ibio Inc.	IBIO	Pharmaceutical Preparations (2834)	262797813

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1053310	Gerald E Kay	Integrated Biopharma, Inc. 225 Long Avenue, Bldg. 15 Hillside NJ 07205		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2012-01-30	10,000	$0.86	4,279,803	No	4	S	Indirect	By EGK, LLC
Common Stock	Disposition	2012-01-30	7,500	$0.88	4,272,303	No	4	S	Indirect	By EGK, LLC
Common Stock	Disposition	2012-01-30	2,500	$0.85	4,269,803	No	4	S	Indirect	By EGK, LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By EGK, LLC
No	4	S	Indirect	By EGK, LLC
No	4	S	Indirect	By EGK, LLC